{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:09:05Z","timestamp":1747181345571,"version":"3.40.5"},"reference-count":37,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8,1]]},"abstract":"<jats:p>Objectives. National recommendations are to use high-dose amoxicillin (80\u201390 mg\/kg per day) to treat uncomplicated acute otitis media (AOM) in children who are at high risk for infection with nonsusceptible Streptococcus pneumoniae (NSSP). However, high-dose treatment may not be necessary if the local prevalence of NSSP is low. The objective of this study was to estimate the local prevalence of NSSP in children with acute upper respiratory illnesses and to develop community-specific recommendations for first-line empiric treatment of AOM.<\/jats:p>\n               <jats:p>Methods. We conducted a cross-sectional prevalence study in the offices of 7 community pediatricians in St Louis, Missouri. S pneumoniae was isolated from nasopharyngeal swabs collected from children who were younger than 7 years and had AOM, nonspecific upper respiratory infection, cough, acute sinusitis, or pharyngitis. Children were excluded from the study when they had received an antibiotic in the previous 4-week period. Parents and providers completed a brief questionnaire to assess risk factors for carriage of NSSP. On the basis of National Clinical Chemistry Laboratory Standards, isolates with a penicillin minimum inhibitory concentration \u22650.12 \u03bcg\/mL were considered to be nonsusceptible to penicillin (NSSP), and isolates with a penicillin minimum inhibitory concentration &amp;gt;2 \u03bcg\/mL were categorized as nonsusceptible to standard-dose amoxicillin (35\u201345 mg\/kg per day; NSSP-A).<\/jats:p>\n               <jats:p>Results. S pneumoniae was isolated from the nasopharynx of 85 (40%) of 212 study patients (95% confidence interval [CI]: 33%\u201347%); 41 (48%) of 85 isolates were NSSP (95% CI: 37%\u201359%), and 6 (7%) were NSSP-A (95% CI: 1.5%\u201313%). Among the 212 study patients, the prevalence of NSSP was 19% (95% CI: 14%\u201325%), and the prevalence of NSSP-A was 3% (95% CI: 0.6%\u20135%). Carriage of NSSP was increased in child care attendees compared with nonattendees (29% vs 14%; odds ratio: 2.6; 95% CI: 1.3\u20135.2).<\/jats:p>\n               <jats:p>Conclusions. In our community, although the prevalence of NSSP among isolates of S pneumoniae identified from the nasopharynx of symptomatic children is high (48%), the probability of NSSP-A infection among symptomatic children is &amp;lt;5%. Our data support a recommendation to treat most children who have uncomplicated AOM with standard-dose amoxicillin. Children who attend child care or have recently received an antibiotic may require treatment with high-dose amoxicillin. Other communities may benefit from a similar assessment of the prevalence of NSSP and NSSP-A.<\/jats:p>","DOI":"10.1542\/peds.114.2.342","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"342-347","source":"Crossref","is-referenced-by-count":12,"title":["Developing Community-Specific Recommendations for First-Line Treatment of Acute Otitis Media: Is High-Dose Amoxicillin Necessary?"],"prefix":"10.1542","volume":"114","author":[{"given":"Jane","family":"Garbutt","sequence":"first","affiliation":[{"name":"Division of General Medical Sciences"},{"name":"Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Joseph W.","family":"St. Geme","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"May","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Storch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope G.","family":"Shackelford","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2004,8,1]]},"reference":[{"key":"2021121006445205200_R1","doi-asserted-by":"crossref","unstructured":"Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Otitis media\u2014principles of judicious use of antimicrobial agents. Pediatrics.1998;101:165\u2013171","DOI":"10.1542\/peds.101.S1.165"},{"key":"2021121006445205200_R2","doi-asserted-by":"crossref","unstructured":"Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobials drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. J Pediatr.1994;124:355\u2013367","DOI":"10.1016\/S0022-3476(94)70356-6"},{"key":"2021121006445205200_R3","doi-asserted-by":"crossref","unstructured":"Nyquist A-C, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA.1998;279:875\u2013877","DOI":"10.1001\/jama.279.11.875"},{"key":"2021121006445205200_R4","doi-asserted-by":"crossref","unstructured":"Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance\u2014a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J.1999;18:1\u20139","DOI":"10.1097\/00006454-199901000-00002"},{"key":"2021121006445205200_R5","doi-asserted-by":"crossref","unstructured":"Klein JO. Otitis media. Clin Infect Dis.1994;19:823\u2013832","DOI":"10.1093\/clinids\/19.5.823"},{"key":"2021121006445205200_R6","doi-asserted-by":"crossref","unstructured":"Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Principles of judicious use of antibacterial agents for pediatric upper respiratory tract infections. Pediatrics.1998;101:163\u2013165","DOI":"10.1542\/peds.101.S1.163"},{"key":"2021121006445205200_R7","unstructured":"Geographic variation in penicillin resistance in Streptococcus pneumoniae\u2014selected sites, United States, 1997. MMWR Morb Mortal Wkly Rep.1999;48:656\u2013661."},{"key":"2021121006445205200_R8","doi-asserted-by":"crossref","unstructured":"Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriological response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J.1996;15:980\u2013985","DOI":"10.1097\/00006454-199611000-00010"},{"key":"2021121006445205200_R9","doi-asserted-by":"crossref","unstructured":"Jacobs MR. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J.2000;19:S47\u2013S56","DOI":"10.1097\/00006454-200005001-00008"},{"key":"2021121006445205200_R10","doi-asserted-by":"crossref","unstructured":"Whitney CG. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med.2000;343:1917\u20131924","DOI":"10.1056\/NEJM200012283432603"},{"key":"2021121006445205200_R11","doi-asserted-by":"crossref","unstructured":"Ghaffar F, Friedland IR, McCracken GH. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae.Pediatr Infect Dis J.1999;18:638\u2013646","DOI":"10.1097\/00006454-199907000-00016"},{"key":"2021121006445205200_R12","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing. Twelfth Informational Supplement. Wayne, PA: NCCLS, 2002 (NCCLS document M100-S12, Vol 22, No 1)"},{"key":"2021121006445205200_R13","doi-asserted-by":"crossref","unstructured":"Craig W, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J.1996;15:255\u2013259","DOI":"10.1097\/00006454-199603000-00015"},{"key":"2021121006445205200_R14","doi-asserted-by":"crossref","unstructured":"Spangler SK, Jacobs MR, Appelbaum PC. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN\/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrob Agents Chemother.1994;38:2902\u20132904","DOI":"10.1128\/AAC.38.12.2902"},{"key":"2021121006445205200_R15","doi-asserted-by":"crossref","unstructured":"Hoberman A, Paradise JL, Block S, Burch DJ, Jacobs MR, Balanescu MI. Efficacy of amoxicillin\/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. Pediatr Infect Dis J.1996;15:955\u2013962","DOI":"10.1097\/00006454-199610000-00034"},{"key":"2021121006445205200_R16","doi-asserted-by":"crossref","unstructured":"Bottenfield GW, Burch DJ, Hedrick JA, Schaten R, Rowinski CA, Davies JT. Safety and tolerability of a new formulation (90 mg\/kg\/day divided every 12 h) of amoxicillin\/clavulanate (Augmentin\u00ae) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J.1998;17:963\u2013968","DOI":"10.1097\/00006454-199810000-00041"},{"key":"2021121006445205200_R17","doi-asserted-by":"crossref","unstructured":"Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin\/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J.2000;19:95\u2013104","DOI":"10.1097\/00006454-200002000-00002"},{"key":"2021121006445205200_R18","doi-asserted-by":"crossref","unstructured":"Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended-spectrum cephalosporins resistance among Streptococcus pneumoniae clinical isolates by use of the E-test. J Clin Microbiol.1994;32:159\u2013163","DOI":"10.1128\/jcm.32.1.159-163.1994"},{"key":"2021121006445205200_R19","doi-asserted-by":"crossref","unstructured":"Schrag SJ, Beall B, Dowell SF. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev.2000;13:588\u2013601","DOI":"10.1128\/CMR.13.4.588"},{"key":"2021121006445205200_R20","doi-asserted-by":"crossref","unstructured":"Eldan M, Leibovitz E, Piglansky L, et al. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children. Pediatr Infect Dis J.2000;19:298\u2013303","DOI":"10.1097\/00006454-200004000-00007"},{"key":"2021121006445205200_R21","doi-asserted-by":"crossref","unstructured":"Gehanno P, Lenoir G, Barry B, Bons J, Boucot I, Berche P. Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children. Pediatr Infect Dis J.1996;15:329\u2013332","DOI":"10.1097\/00006454-199604000-00009"},{"key":"2021121006445205200_R22","doi-asserted-by":"crossref","unstructured":"Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study. Antimicrob Agents Chemother.1999;43:1901\u20131908","DOI":"10.1128\/AAC.43.8.1901"},{"key":"2021121006445205200_R23","doi-asserted-by":"crossref","unstructured":"Pichichero ME. Antibiotic resistance changes in sinusitis and otitis media pathogens. Pediatr Asthma Allergy Immunol.1998;12:235\u2013240","DOI":"10.1089\/pai.1998.12.235"},{"key":"2021121006445205200_R24","doi-asserted-by":"crossref","unstructured":"Lister PD, Pong A, Chartrand A, Sanders CC. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies. Antimicrob Agents Chemother.1997;41:1926\u20131932","DOI":"10.1128\/AAC.41.9.1926"},{"key":"2021121006445205200_R25","doi-asserted-by":"crossref","unstructured":"Parra A, Ponte C, Cenjor C, et al. Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus in the gerbil model. Antimicrob Agents Chemother.2002;46:859\u2013862","DOI":"10.1128\/AAC.46.3.859-862.2002"},{"key":"2021121006445205200_R26","doi-asserted-by":"crossref","unstructured":"Schrag SJ, Pena C, Fernandez J, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage. JAMA.2001;286:49\u201356","DOI":"10.1001\/jama.286.1.49"},{"key":"2021121006445205200_R27","doi-asserted-by":"crossref","unstructured":"McCracken GH. Prescribing antimicrobial agents for treatment of acute otitis media. Pediatr Infect Dis J.1999;18:1141\u20131146","DOI":"10.1097\/00006454-199912000-00029"},{"key":"2021121006445205200_R28","doi-asserted-by":"crossref","unstructured":"Klein JO. Clinical implications of antibiotic resistance for management of acute otitis media. Pediatr Infect Dis J.1998;17:1084\u20131089","DOI":"10.1097\/00006454-199811000-00039"},{"key":"2021121006445205200_R29","unstructured":"CDC. Active Bacterial Core Surveillance. Surveillance Report; 2001. Available at: www.cdc.gov\/ncidod\/dbmd\/abcs"},{"key":"2021121006445205200_R30","doi-asserted-by":"crossref","unstructured":"Yagupsky P, Porat N, Fraser D, et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis.1998;177:1003\u20131012","DOI":"10.1086\/515239"},{"key":"2021121006445205200_R31","unstructured":"Faden H, Stanievich J, Brodsky L, Bernstein J, Ogra PL. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J.1990;9:623\u2013626"},{"key":"2021121006445205200_R32","doi-asserted-by":"crossref","unstructured":"Boken DJ, Chartrand SA, Smith Moland E, Goering RV. Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centers. Pediatr Infect Dis J.1996;15:667\u2013672","DOI":"10.1097\/00006454-199608000-00006"},{"key":"2021121006445205200_R33","doi-asserted-by":"crossref","unstructured":"Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J.1995;14:745\u2013750","DOI":"10.1097\/00006454-199509000-00004"},{"key":"2021121006445205200_R34","doi-asserted-by":"crossref","unstructured":"Roos K, Hakansson EG, Holm S. Effect of recolonization with \u201cinterfering\u201d \u03b1 streptococci on recurrences of acute and secretory otitis media in children: randomized placebo controlled trial. BMJ.2001;322:1\u20134","DOI":"10.1136\/bmj.322.7280.210"},{"key":"2021121006445205200_R35","doi-asserted-by":"crossref","unstructured":"Hyde TB, Gay K, Stephens DS, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA.2001;286:1857\u20131862","DOI":"10.1001\/jama.286.15.1857"},{"key":"2021121006445205200_R36","doi-asserted-by":"crossref","unstructured":"Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J.2003;22:10\u201316","DOI":"10.1097\/00006454-200301000-00006"},{"key":"2021121006445205200_R37","unstructured":"Whitney CG, Farley MM, Hadler J, et al. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med.2003;348:1737\u20131746"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/114\/2\/342\/1017184\/zpe00804000342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/114\/2\/342\/1017184\/zpe00804000342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T15:32:49Z","timestamp":1639150369000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/114\/2\/342\/64644\/Developing-Community-Specific-Recommendations-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,1]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,8,1]]},"published-print":{"date-parts":[[2004,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.114.2.342","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2004,8,1]]}}}